Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL	Children’s Research Institute / Kristina Hardy, PhD	Psychosocial Grants	2014	District of Columbia
Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL	Columbia University / Adolfo A. Ferrando, M.D., Ph.D.	Innovation Grants	2014	New York
Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients	Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD	Young Investigator Grants	2014	Massachusetts
Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy	Dana-Farber Cancer Institute / Yana Pikman, MD	Young Investigator Grants	2014	Massachusetts
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma	Dana-Farber Cancer Institute / Thomas Look, M.D.	Innovation Grants	2014	Massachusetts
SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia	Dana-Farber Cancer Institute / Brenton Mar, MD, PhD	Young Investigator Grants	2014	Massachusetts
Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer	Dana-Farber Cancer Institute / Rani George, M.D., Ph.D.	Innovation Grants	2014	Massachusetts
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells	Dana-Farber Cancer Institute / Zhaodong Li, PhD	Young Investigator Grants	2014	Massachusetts
Therapies for SHH-subtype Medulloblastoma	Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D.	Innovation Grants	2014	Massachusetts
The Role of MST1 in Non-canonical Hippo Signaling in Rhabdomyosarcoma	Duke University / Lisa Crose, Ph.D.	'A' Award Grants	2014	North Carolina

Pages